Transradial Closure Devices Market - Top Companies and Manufacturers

  • Report ID: 4346
  • Published Date: Jul 26, 2024
  • Report Format: PDF, PPT

Companies Dominating the Transradial Closure Devices Landscape

top-features-companies
    • Medtronic plc

      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Teleflex Incorporated
    • Merit Medical Systems, Inc.
    • Abbott Laboratories
    • Fisher & Paykel Healthcare Corporation Limited
    • Beijing Demax Medical Technology Co., Ltd.
    • Semler Technologies, Inc.
    • Endocor GmbH
    • Morris Innovative, Inc.
    • Transluminal Technologies, LLC 

Browse Key Market Insights with Data Illustration:

In the News

  • Medtronic plc announced the completion of the acquisition of Affera, Inc. With this acquisition, the company expands its cardiac ablation portfolio with the first integrated cardiac mapping and navigation platform that encompasses fully integrated diagnostics, focal pulsed fields, and radiofrequency ablation solutions.

  • Teleflex Incorporated stated it has received Health Canada approval for its MANTA Vascular Closure Device - the first commercially available biomechanical closure device specifically designed for large bore femoral arterial access sites


Author Credits:  Radhika Pawar


  • Report ID: 4346
  • Published Date: Jul 26, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of transradial closure devices is evaluated at USD 273.38 Million.

The transradial closure devices market size was valued at USD 251.85 Million in 2023 and is set to exceed USD 819.46 Million by the end of 2036, registering over 9.5% CAGR during the forecast period i.e., between 2024-2036. Worldwide spike in coronary artery disease (CAD), growing prevalence of strokes, escalation of lifestyle diseases, and raising cholesterol levels are some major factors driving the growth of the market in the forecast period.

North America is projected to account for largest industry share by 2036, driven by high prevalence of heart disease in the region along with the increasing geriatric population, and accessibility of advanced healthcare facilities.

Medtronic plc, Teleflex Incorporated, Merit Medical Systems, Inc., Abbott Laboratories, Fisher & Paykel Healthcare Corporation Limited, Beijing Demax Medical Technology Co., Ltd., Semler Technologies, Inc., Endocor GmbH, Morris Innovative, Inc., Transluminal Technologies, LLC
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying